Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral methotrexate for pain reduction in knee osteoarthritis
ISRCTN66676866Phase 4Completed
- Sponsor
- University of Leeds
- Start
- Jul 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
01
Overview
Phase 4, open-label, single-arm trial of methotrexate in knee osteoarthritis (OA), sponsored by University of Leeds. Primary endpoint: Change in knee pain visual analogue scale score at 24 weeks. Started Jul 2009; status: completed.
02
Drugs
methotrexate
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ISRCTN66676866.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN66676866.